1. Home
  2. STG vs IMUX Comparison

STG vs IMUX Comparison

Compare STG & IMUX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STG
  • IMUX
  • Stock Information
  • Founded
  • STG 2003
  • IMUX 2016
  • Country
  • STG China
  • IMUX United States
  • Employees
  • STG N/A
  • IMUX N/A
  • Industry
  • STG Other Consumer Services
  • IMUX Biotechnology: Pharmaceutical Preparations
  • Sector
  • STG Real Estate
  • IMUX Health Care
  • Exchange
  • STG Nasdaq
  • IMUX Nasdaq
  • Market Cap
  • STG 91.6M
  • IMUX 86.3M
  • IPO Year
  • STG 2018
  • IMUX N/A
  • Fundamental
  • Price
  • STG $6.82
  • IMUX $0.98
  • Analyst Decision
  • STG
  • IMUX Strong Buy
  • Analyst Count
  • STG 0
  • IMUX 6
  • Target Price
  • STG N/A
  • IMUX $12.67
  • AVG Volume (30 Days)
  • STG 10.9K
  • IMUX 1.0M
  • Earning Date
  • STG 03-21-2025
  • IMUX 02-20-2025
  • Dividend Yield
  • STG N/A
  • IMUX N/A
  • EPS Growth
  • STG N/A
  • IMUX N/A
  • EPS
  • STG 4.57
  • IMUX N/A
  • Revenue
  • STG $292,030,936.00
  • IMUX N/A
  • Revenue This Year
  • STG N/A
  • IMUX N/A
  • Revenue Next Year
  • STG N/A
  • IMUX N/A
  • P/E Ratio
  • STG $1.45
  • IMUX N/A
  • Revenue Growth
  • STG N/A
  • IMUX N/A
  • 52 Week Low
  • STG $4.25
  • IMUX $0.92
  • 52 Week High
  • STG $12.55
  • IMUX $2.11
  • Technical
  • Relative Strength Index (RSI)
  • STG 57.89
  • IMUX 44.34
  • Support Level
  • STG $6.51
  • IMUX $0.94
  • Resistance Level
  • STG $6.78
  • IMUX $1.02
  • Average True Range (ATR)
  • STG 0.26
  • IMUX 0.06
  • MACD
  • STG 0.04
  • IMUX 0.00
  • Stochastic Oscillator
  • STG 80.49
  • IMUX 44.96

About STG Sunlands Technology Group

Sunlands Technology Group is a provider of online post-secondary and professional education services in China. The company offers various degree- and diploma-oriented post-secondary courses through its online platforms. In addition, it provides online professional courses and educational content to help students prepare for professional certification exams and attain professional skills. The Group has one operating segment, which is the provision of online education services.

About IMUX Immunic Inc.

Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.

Share on Social Networks: